You are here: All Products  > Xuanzhu, a Novel Drug Subsidiary of Sihuan Pharm, Completes $96 Million Round

Xuanzhu, a Novel Drug Subsidiary of Sihuan Pharm, Completes $96 Million Round

Price: $5.00
Available

Get instant access to this article for unlimited viewing and/or downloading for seven days.


Back to products